Serotonin-immune interactions in major depression: Lower serum tryptophan as a marker of an immune-inflammatory response

European Archives of Psychiatry and Clinical Neuroscience

Volumn 247, Issue 3, 1997, Pages 154-161

  Maes, Michael ^a,b   Verkerk, Robert ^c   Vandoolaeghe, Eric ^a   Van Hunsel, Fran ^a   Neels, Hugo ^d   Wauters, Annick ^d   Demedts, Paul ^d   Scharpé, Simon ^c  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

Acute phase response; Cytokines; Immunology; Serotonin; Tryptophan

Indexed keywords

ALBUMIN; ANTIDEPRESSANT AGENT; CD4 ANTIGEN; CD8 ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LEUCINE; PHENYLALANINE; PLASMA PROTEIN; SEROTONIN; TRANSFERRIN; TRYPTOPHAN; TYROSINE; VALINE; ZINC;

ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; IRON BLOOD LEVEL; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TRANSFERRIN BLOOD LEVEL; ZINC BLOOD LEVEL;

EID: 0030920138     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033069     Document Type: Article

References (59)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R) 3rd edn, revised. American Psychiatric Press, Washington, DC
2. Ashcroft GW, Blackburn IM, Eccelston D, Glen AIM, Hartley W, Kinloch NE, Lonergan M, Murray LG, Pullar IA (1973) Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness. Psychol Med 3:319-325
3. Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20:37-46
4. Curzon G (1990) Availability of amino acids to the brain and implication for transmitter amine function. In: Richardson MA (ed) Amino acids in psychiatric disease. American Psychiatric Press, Washington DC, pp 33-48
5. Curzon G, Sarna GS (1984) Tryptophan transport to the brain: newer findings and older ones reconsidered. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyler, Berlin, pp 145-157
6. Deakin JF, Pennell I, Upadhyaya AJ, Lofthouse R (1990) A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 101:85-92
7. Deger O, Bekaroglu M, Orem A, Orem S, Uluutku N, Soylu C (1996) Polymorphonuclear (PMN) elastase levels in depressive disorders. Biol Psychiatry 39:357-363
8. Delgado PL, Charney DS, Price LH, Landis H, Heninger GR (1990) Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci 45:2323-2332
9. DeMyer MK, Shea PA, Hendric HG, Yoshimura NN (1981) Plasma tryptophan and five other amino acids in depressed and normal subjects. Arch Gen Psychiatry 38:642-646
10. Dinarello CA (1991) Interleukin-1. In: Thompson AW (ed) The cytokine handbook. Academic Press, London, pp 47-82
11. Fernstrom JD (1984) Tryptophan availability and serotonin synthesis in rat brain: effects of experimental diabetes. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter, Berlin, pp 161-172
12. Fuchs D, Moller AA, Reibnegger G, Stockle E, Werner ER, Wachter H (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J AIDS 3:873-876
13. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-61
14. Healy D, Carney PA, Leonard BE (1983) Monoamine-related markers of depression: changes following treatment. J Psychiatry Res 17:251-260
15. Heninger GR, Delgado PL, Charney DS, Price LH, Aghajanian GK (1992) Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients. J Chem Neuroanat 5:347-348
16. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP (1992) Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-infected patients. J Neuroimmunol 40:71-80
17. Hirano T (1991) Interleukin-6. In: Thomson AW (ed) The cytokine handbook. Academic Press, London, pp 169-190
18. Holmes EW, Russell PM, Kinzler GJ, Reckard CR, Flanigan RC, Thompson KD, Bermes EW (1992) Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapy. Cytokine 4:205-213
19. Lee WH, Woodward BD (1996) The CD4/CD8 ratio in the blood does not reflect the response of this index in secondary lymphoid organs of wealing mice in models of protein-energy malnutrition known to depress thymus-dependent immunity. J Nutr 126:849-859
20. Lucca A, Lucini V, Catalano M, Alfano M, Smeraldi E (1994) Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor. Neuropsychobiology 29:108-111
21. McMenamy RH, Oncley JL (1958) The specific binding of L-tryptophan to serum albumin. J Biol Chem 233:1436-1440
22. Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Progr Psychopharmacol Biol Psychiatry 19:11-38
23. Maes M, Meltzer HYM (1995) The serotonin hypothesis of major depression. In: Bloom F, Kupher D (eds) Pschopharmacology: the fourth generation of progress. Raven Press, New York, pp 933-944
24. Maes M, Schotte C, Scharpé S, Martin M, Blockx P (1990) The effects of glucocorticoids on the availability of L-trytophan and tyrosine in the plasma of depressed patients. J Affect Disord 18 :121-127
25. Maes M, Bosmans E, Meltzer HY, Scharpé S, Suy E (1993a) Interleukin-1β: a putative mediator of HPA-axis hyperactivity in major depression? Am J Psychiatry 150:1189-1193
26. Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, Minner B, Meester I de, Calabrese J, Vandervorst C, Raus J, Cosyns P (1993b) Relationships between lower plasma L-tryptophan levels and immune variables in depression. Psychiatr Res 49: 11-27
27. Maes M, Langhe J de, Scharpé S, Meltzer HY, Cosyns P, Suy E, Bosmans E (1994a) Haptoglobin phenotypes and gene frequencies in unipolar major depression. Am J Psychiatry 151: 112-116
28. Maes M, Meltzer HY, Cosyns P, Schotte C (1994b) Evidence for the existence of major depression with and without anxiety features. Psychopathology 27:1-13
29. Maes M, Scharpé S, D'Haese W, Broe M de, Cosyns P (1994c) Hypozincaemia in depression. J Affect Disord 31:135-140
30. Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche B, Cosyns P (1994d) Increased neopterin and interferon γ secretion and lower availability of L-tryptophan in major depression: further evidence for activation of cell-mediated immunity. Psychiatr Res 54:143-160
31. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995a) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34:301-309
32. Maes M, Smith R, Scharpé S (1995b) The monocyte-T lymphocyte hypothesis of major depression. Invited editorial. Psychoneuroendocrinology 20:111-116
33. Maes M, Vandevyvere J, Vandoolaeghe E, Bril T, Vandoolaeghe E, Neels H (1996a) Disorders in iron metabolism and the erythron in major depression: further evidence for an inflammatory response. J Affect Disord 40:23-33
34. Maes M, Wauters A, Verkerk R, Neels H, Van Gastel A, Cosyns P, Scharpé S, Desnyder R (1996b) Lower L-tryptophan availability in depression: a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacol 15:243-251
35. Marten NW, Burke EJ, Hayden JM, Straus DS (1994) Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells. FASEB J 8:538-544
36. Moir ATB, Eccleston D (1968) The effect of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J Neurochem 15: 1093-1108
37. Moldawer LL, Georgieff M, Lundholm K (1987) Interleukin-1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol 7:263-274
38. Møller SE (1985) Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments. Acta Psychiatr Scand (Suppl) 72:1-30
39. Møller SE, Beurs P de, Timmerman L, Tan BK, Leynse-Ybema HJ, Cohen Stuart MH, Hopfner Petersen HE (1986) Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline: a preliminary study. Psychopharmacology 88:96-100
40. Muller N (1995) Psychoneuroimmunology: implications for the drug treatment of psychiatric disorders. CNS Drugs 4:125-140
41. Pardridge WM (1979) Tryptophan transport through the blood-brain barrier: in vivo measurement of free and albumin-bound amino acid. Life Sci 25:1519-1528
42. Perez-Cruet J, Chase TN, Murphy DL (1974) Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans. Nature 248:693-695
43. Russ MJ, Ackerman SH, Banay-Schwartz M, Shindledecker RD, Smith GP (1990) Plasma tryptophan to large neutral amino acid ratios in depressed and normal subjects. J Affect Disord 19: 9-14
44. Sainio E-L, Pulkki K, Young SN (1996) L-tryptophan: biochemical, nutritional and pharmacological aspects. Amino Acids 10: 21-47
45. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1996a) Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand 94:198-204
46. + natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78: 83-85
47. Sluzewska A, Nowakowsky E, Gryska K, Machkiewicz A (1994) Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatment. Eur Neuropharmacol P-1-18: 302
48. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowiz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762:474-476
49. 1-acid glycoprotein in major depressive disorder. J Affect Disord 39: 149-155
50. Smith SE, Pihl RO, Young SW, Ervin FR (1987) A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology 91:451-457
51. Smith QR, Fukui S, Robinson P, Rapaport SI (1990) Influence of cerebral blood flow on tryptophan uptake into brain. In: Lubec G, Rosenthal GA (eds) Amino acids: chemistry, biology and medicine. Escom, Leiden, pp 364-369
52. Song C, Leonard BE (1994) An acute phase protein response in the olfactory bulbectomized rat: effect of sertraline treatment. Med Sci Res 22:313-314
53. Song C, Dinan T, Leonard BE (1994) Changes in immunoglobublin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30:283-288
54. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Structured Clinical Interview according to DSM-III-R. American Press, New York
55. Takikawa O, Yoshida R, Yasui H, Hayaishi O (1984) The relationship between plasma kynurenine and indoleamine 2,3-dioxygenase activity in the extrahepatic tissues. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter, Berlin, pp 517-520
56. Thase ME, Rush AJ (1995) Treatment-resistant depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1081-1098
57. Walser M, Hill SB (1993) Free and protein-bound tryptophan in serum of untreated patients with chronic renal failure. Kidney Int 44:1366-1371
58. Young SN, Smith SE, Pihl R, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173-177
59. Yuwiler A, Oldendorf WH, Geller E et al. (1977) The effect of albumin binding and amino acid composition on tryptophan uptake into the brain. J Neurochem 28:1015-1023